Clinical trials: BRVO - Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion With Macular Edema

Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

• Unknown status
• Age: 18 years and older
• Phase 4
• Injection or infusion
• Medical device

To evaluate the efficacy of sequential therapy with intravitreal dexamethasone implant followed by bevacizumab compared with bevacizumab monotherapy for macular edema (ME) secondary to retinal vein occlusion (RVO).

Trial name

NCT03892434

Testing

Intravitreal bevacizumab and dexamethasone implant Injection, Intravitreal dexamethasone implant

Where

South Korea

Volunteers

40 people

Sponsor

Yeungnam University College of Medicine